Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Herbert Alexander

Dermatology Johns Creek, GA Medical Doctor

NPI 1093992588 CMS profile 276854

6470 E Johns Xing Ste 200, Johns Creek, GA 30097

Open in the dashboard

General payments

$5,645

268 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Herbert Alexander of Johns Creek, GA is reported in the CMS Open Payments database as having received $5,645 across 268 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $915 29
2024 General $908 33
2023 General $398 19
2022 General $813 43
2021 General $719 39
2020 General $863 45
2019 General $1,029 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Herbert Alexander
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Herbert Alexander were reported at $915. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Herbert Alexander Dermatology median Middle half National median
2019 $1,029 $454 $129–$1,240 $163
2020 $863 $235 $81–$756 $114
2021 $719 $377 $108–$1,108 $132
2022 $813 $514 $143–$1,391 $149
2023 $398 $607 $159–$1,674 $160
2024 $908 $751 $204–$1,903 $164
2025 $915 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $936 49 payments
  2. LEO Pharma Inc. $615 38 payments
  3. Janssen Biotech, Inc. $479 12 payments
  4. Genzyme Corporation $454 14 payments
  5. Galderma Laboratories, L.P. $398 24 payments
  6. Allergan Inc. $356 19 payments
  7. Incyte Corporation $326 16 payments
  8. Ortho Dermatologics, a division of Bausch Health US, LLC $323 17 payments
  9. Almirall LLC $234 12 payments
  10. Regeneron Healthcare Solutions, Inc. $206 9 payments
  11. Other $1,318 58 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,255 264 payments
  2. Education $390 4 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $484 11 payments
  2. TREMFYA $479 12 payments
  3. RINVOQ $349 20 payments
  4. SKYRIZI $346 18 payments
  5. OPZELURA $326 16 payments
  6. HUMIRA $264 14 payments
  7. BOTOX $211 11 payments
  8. DUPIXENT Inflammation And Immunology $206 9 payments
  9. Seysara $189 10 payments
  10. ADBRY $172 11 payments
  11. Other $3,073 160 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

357

Median for Dermatology: 534

Drug cost

$7,553

Median for Dermatology: $67,151

Branded share of claims

7%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 32 $1,353
Fluorouracil Generic 16 $1,069
Valacyclovir Valacyclovir Hcl Brand 25 $1,022
Fluocinonide Generic 27 $1,007
Triamcinolone Acetonide Generic 62 $752
Imiquimod Generic 27 $697
Hydrocortisone Generic 54 $605
Doxycycline Hyclate Generic 27 $347
Minoxidil Generic 25 $277
Econazole Nitrate Generic 13 $164

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$40,503

Medicare's payments for the services billed

Medicare patients

216

Average age 75

Services billed

760

95 women, 121 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 56%
Arthritis 41%
Ischemic heart disease 27%
Diabetes 15%
Cancer 13%
Depression 13%
Atrial fibrillation 11%
Chronic kidney disease 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $160
  • SANOFI-AVENTIS U.S. LLC $95
$255 — —
TREMFYA
  • Janssen Biotech, Inc. $136
$136 — —
RINVOQ
  • AbbVie, Inc. $120
$120 — —
SKYRIZI
  • AbbVie, Inc. $117
$117 — —
CIBINQO
  • PFIZER INC. $34
$34 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

268 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record